Cargando…

Primary pulmonary lymphoma in Peru

OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enferm...

Descripción completa

Detalles Bibliográficos
Autores principales: Requena, Elily Dianet Apumayta, Ocrospoma, Danery Valdez, Ruiz, Jhonatanael Salvador, De la Guerra Pancorvo, Alberto, Kajatt, Edgar Amorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310327/
https://www.ncbi.nlm.nih.gov/pubmed/37396099
http://dx.doi.org/10.3332/ecancer.2023.1559
_version_ 1785066515167444992
author Requena, Elily Dianet Apumayta
Ocrospoma, Danery Valdez
Ruiz, Jhonatanael Salvador
De la Guerra Pancorvo, Alberto
Kajatt, Edgar Amorin
author_facet Requena, Elily Dianet Apumayta
Ocrospoma, Danery Valdez
Ruiz, Jhonatanael Salvador
De la Guerra Pancorvo, Alberto
Kajatt, Edgar Amorin
author_sort Requena, Elily Dianet Apumayta
collection PubMed
description OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enfermedades Neoplásicas in Lima, Perú. RESULTS: 73.9% of patients were male. Cough (78.3%) and weight loss (56.5%) were the most frequent clinical features. Dyspnoea and elevated values of DHL and B2 microglobulin were frequently altered in advanced stages. Diffuse large B cell lymphoma (DLBCL) represented 47.8% of the cases and the most common radiologic alterations were a mass (60%) and consolidation with air bronchogram (60%). The most utilised treatment was chemotherapy alone (60%). Three patients received only surgery. Median survival was 30 months. Five overall survival was 45%, and up to 60% in the case of mucosa-associated lymphoid tissue lymphoma. CONCLUSION: PPL is infrequent. Clinical features are unspecific and the principal finding is a mass, nodule or consolidation with air bronchogram. Definitive diagnosis needs biopsy and immunohistochemistry. There is no standard treatment, it depends on histology type and stage.
format Online
Article
Text
id pubmed-10310327
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-103103272023-06-30 Primary pulmonary lymphoma in Peru Requena, Elily Dianet Apumayta Ocrospoma, Danery Valdez Ruiz, Jhonatanael Salvador De la Guerra Pancorvo, Alberto Kajatt, Edgar Amorin Ecancermedicalscience Research OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enfermedades Neoplásicas in Lima, Perú. RESULTS: 73.9% of patients were male. Cough (78.3%) and weight loss (56.5%) were the most frequent clinical features. Dyspnoea and elevated values of DHL and B2 microglobulin were frequently altered in advanced stages. Diffuse large B cell lymphoma (DLBCL) represented 47.8% of the cases and the most common radiologic alterations were a mass (60%) and consolidation with air bronchogram (60%). The most utilised treatment was chemotherapy alone (60%). Three patients received only surgery. Median survival was 30 months. Five overall survival was 45%, and up to 60% in the case of mucosa-associated lymphoid tissue lymphoma. CONCLUSION: PPL is infrequent. Clinical features are unspecific and the principal finding is a mass, nodule or consolidation with air bronchogram. Definitive diagnosis needs biopsy and immunohistochemistry. There is no standard treatment, it depends on histology type and stage. Cancer Intelligence 2023-06-15 /pmc/articles/PMC10310327/ /pubmed/37396099 http://dx.doi.org/10.3332/ecancer.2023.1559 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Requena, Elily Dianet Apumayta
Ocrospoma, Danery Valdez
Ruiz, Jhonatanael Salvador
De la Guerra Pancorvo, Alberto
Kajatt, Edgar Amorin
Primary pulmonary lymphoma in Peru
title Primary pulmonary lymphoma in Peru
title_full Primary pulmonary lymphoma in Peru
title_fullStr Primary pulmonary lymphoma in Peru
title_full_unstemmed Primary pulmonary lymphoma in Peru
title_short Primary pulmonary lymphoma in Peru
title_sort primary pulmonary lymphoma in peru
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310327/
https://www.ncbi.nlm.nih.gov/pubmed/37396099
http://dx.doi.org/10.3332/ecancer.2023.1559
work_keys_str_mv AT requenaelilydianetapumayta primarypulmonarylymphomainperu
AT ocrospomadaneryvaldez primarypulmonarylymphomainperu
AT ruizjhonatanaelsalvador primarypulmonarylymphomainperu
AT delaguerrapancorvoalberto primarypulmonarylymphomainperu
AT kajattedgaramorin primarypulmonarylymphomainperu